Search

Learn more about the first facility in the world devoted to the specific needs of colorectal cancer patients under the age of 50.

… Monday, March 8, 2021 Summary A troubling rise in colorectal cancer among younger adults has led experts to advise issuing new guidelines that lower the recommended age when people should begin colorectal screenings from 50 to 45. In 2018, MSK established the first facility in the world devoted to the

Obtenga más información sobre el primer centro en el mundo dedicado a las necesidades específicas de los pacientes con cáncer colorrectal menores de 50 años.

… Monday, March 8, 2021 Resumen Un aumento preocupante de casos de cáncer colorrectal entre los adultos más jóvenes ha llevado a los expertos a sugerir que se publiquen nuevas pautas que reduzcan la edad recomendada en que las personas deben comenzar a hacerse las pruebas de detección colorrectal de los

Local control rates and overall survival (OS) were significantly higher for patients with brain metastases treated with adjuvant stereotactic radiosurgery (SRS) within two months of resection, compared to longer time intervals, according to our new study published recently in Neuro-Oncology Practice.

… Thursday, September 23, 2021 Local control rates and overall survival (OS) were significantly higher for patients with brain metastases treated with adjuvant stereotactic radiosurgery (SRS) within two months of resection, compared to longer time intervals, according to our new study published recently

A landmark study led in part by physician-researchers from Memorial Sloan Kettering is giving new hope to some people with metastatic colorectal cancer.

… Wednesday, December 23, 2020 A landmark study led in part by physician-researchers from Memorial Sloan Kettering is giving new hope to some people with metastatic colorectal cancer. In a recent issue of the  New England Journal of Medicine , results from the phase III study — Keynote 177 — provided further

一项由纪念斯隆凯特琳的医生-研究人员部分主导的具有里程碑意义的研究给部分转移性结直肠癌患者带来新的希望。

… Wednesday, December 23, 2020 一项由纪念斯隆凯特琳的医生-研究人员部分主导的具有里程碑意义的研究给部分转移性结直肠癌患者带来新的希望。 在最近一期的 《新英格兰医学杂志》 上，III 期研究 (Keynote 177) 的结果提供了进一步相关证据，证明当用作一线治疗时， 免疫治疗 药物帕博利珠单抗 可改善不可切除及微卫星不稳定性-高 (MSI-H) /错配修复缺陷 (dMMR) 转移性结直肠癌患者的疾病进展。 今年 6 月，帕博利珠单抗获得 FDA 突破性疗法的认定 ，用于该亚组患者的治疗。 大约 5% 的转移性结直肠癌患者患有 MSI-H/dMMR 类型的疾病。 在癌症中

The Starr Foundation is continuing its longstanding commitment to stem cell research in New York City with a $50 million gift in support of the Tri-Institutional Stem Cell Initiative (Tri-SCI), a research collaboration between Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medicine.

… Thursday, April 4, 2019 The Starr Foundation is continuing its longstanding commitment to stem cell research in New York City with a $50 million gift in support of the Tri-Institutional Stem Cell Initiative (Tri-SCI), a research collaboration between Memorial Sloan Kettering Cancer Center, The Rockefeller

Learn more about how a clinical trial at MSK revealed important connections between the foods we eat and our cancer risk.

… Monday, December 8, 2025 If you or a loved one is facing cancer, you may wish you could regain some sense of control when so much feels beyond your power. You may wonder what you can or should eat. Comfort food? Healthy food? How much does it matter? The effort at Memorial Sloan Kettering Cancer Center

The initiative lays the groundwork for speedier cancer drug approvals in both the United States and China.

… Tuesday, December 22, 2020 Summary The 3rd annual MSK-CTONG Symposium virtually brought together leading medical experts, including academic physicians, scientific leadership from pharmaceutical and biotechnology industries, as well as government regulators, to discuss US-China and international clinical

该计划为中美两国加快批准抗癌药物奠定了基础。

… Tuesday, December 22, 2020 总结 第 3 届年度 MSK-CTONG 研讨会通过线上的方式汇集了顶尖医学领域专家，包括学术性医师、来自制药和生物技术行业的科学带头人以及政府监管机构专家，共同探讨中美及国际临床试验。MSK 斯隆首席医生 Lisa DeAngelis 重申了 MSK 斯隆致力于支持和促进 MSK-CTONG 合作的机构承诺。澳大利亚第 26 任总理、亚洲学会第八届总裁兼 CEO 陆克文 (Kevin Rudd) 以英文和普通话发表了主题演讲，强调了中美合作共同抗击癌症的重要性。来自美国食品药品监督管理局 (FDA) 的 Richard Pazdur 博士和

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce Eileen M. O’Reilly, MD; Howard I. Scher, MD; and Deb Schrag, MD, MPH, have been elected to the 11th class of Giants of Cancer Care® for their contributions to gastrointestinal cancer care, genitourinary cancer care, and prevention and care delivery respectively.

… Thursday, May 4, 2023 Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce Eileen M. O’Reilly, MD ; Howard I. Scher, MD ; and Deb Schrag, MD, MPH , have been elected to the 11 th class of Giants of Cancer Care® for their contributions to gastrointestinal cancer care, genitourinary cancer